Pirtobrutinib,Ibrutinib
eli lilly
['lymphoma', 'leusm', 'bruin cll-314', 'leukemia', 'ibru', 'lymsm', 'bruin', 'cll', 'valent ,(-prevalent),(-equivalent),(-bivalent)', 'valent ,(-prevalent)', 'loxo']
trial in progress at #asco23: bruin cll-314: a phase 3, open-label, randomized study of a non-covalent (reversible) btki vs. ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll). #leusm #lymsm learn more here: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK